SANUWAVE Health, Inc. - 8-K Filing

Sanuwave Health reported Q1 2026 revenue of $9.6 million, up 3.1% from $9.3 million in the same period last year, with gross margin at 77.3%. The company swung to a GAAP operating loss of $1.1 million compared to an operating income of $0.6 million in Q1 2025 and provided guidance for revenue growth of 10-15% in Q2 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $SNWV

Read the full article at SEC EDGAR

More Regulatory news